Teens Age 12-17 with Asthma

Trial Objective

Teen Asthma Investigational MedicationThe purpose of this study is to determine if an investigational medication, Fevipiprant, improves breathing in teens with uncontrolled asthma.

Study details:

  • 9 visits to National Jewish Health over a 5 month period
  • Investigational medicine is taken in addition to standard-of-care therapy and is in the form of a pill
  • Medical evaluations (including breathing tests and physical examinations) at no cose
  • Asthma education
  • Financial compensation for time and travel for qualified participants


New enrollment for this trial is temporarily paused

Who Can Participate

Teens age 12-17 with a diagnosis of asthma for at least six months who are being treated with daily asthma medications may be eligible to participate.

Age: 12-17    Gender: Any Gender

Estimated Time Commitment

About 9 visits over approximately 19 weeks

Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Michael White

Michael White

D Sundstrom

Dee Sundstrom

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Novartis Pharmaceuticals Corporation

Request More Information

After limiting clinical research activity due to safety concerns about COVID-19, we are now restarting clinical research in stages. If you are interested in any of the clinical trials posted on our website, please request trial information. We will respond and share the timing for enrollment resuming. Learn More